The company, which has recently opened a clinic and lab in Medellin, Colombia, is dedicated to developing top treatment options and operating clinics that offer state-of-the-art treatment options. They aim to commercialize stem cell technologies and science, not only for financial gain but also to provide new healthcare options that were previously unavailable. Bioscience Americas is actively advocating for new regulations and changing the perception of stem cell therapy with various world governing bodies. With over $400 million and more than fifteen years of experience in adult stem cell research and treatment, the company is partnering with BioXcellerator to build stem cell rejuvenation and regeneration wellness centers in South America. Their vision is to open wellness centers on all five continents, and their association with BioXcellerator ensures ongoing research and the provision of FDA-approved treatment protocols and clinical trial participation. Additionally, Bioscience Americas is an international development partner of the Global Institute of Stem Cell Therapy and Research.